Microembolic signal monitoring of TOAST‑classified cerebral infarction patients

Jiang,Jiandong; Jiang,Yulong; Feng,Shouqin; Sun,Dejin; Zhuang,Aixia; Zeng,Qinghong; Zhang,Yi; Huang,Hongmei; Nie,Hongxia; Zhou,Fang

doi:10.3892/mmr.2013.1609

Microembolic signal monitoring of TOAST‑classified cerebral infarction patients

Authors:
- Jiandong Jiang
- Yulong Jiang
- Shouqin Feng
- Dejin Sun
- Aixia Zhuang
- Qinghong Zeng
- Yi Zhang
- Hongmei Huang
- Hongxia Nie
- Fang Zhou
View Affiliations

Affiliations: Department of Neurology, Lianyungang Second Hospital, Lianyungang, Jiangsu 222006, P.R. China, Department of Neurological Examination, Lianyungang Second Hospital, Lianyungang, Jiangsu 222006, P.R. China, Department of Radiology, Lianyungang Second Hospital, Lianyungang, Jiangsu 222006, P.R. China, Department of Ultrasound, Lianyungang Second Hospital, Lianyungang, Jiangsu 222006, P.R. China
Published online on: August 1, 2013 https://doi.org/10.3892/mmr.2013.1609
Pages: 1135-1142

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effects of microembolic signals (MES) on post‑stroke neurological deficits, stroke recurrence and survival in patients with acute cerebral infarction (CI). Patients with acute CI were enrolled consecutively and classified etiologically into the following 4 subtypes using the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification: i) Cardioembolism (CE); ii) large‑artery atherosclerosis (LA); iii) small‑vessel disease (SVD); and iv) stroke of other etiology, including other and undetermined etiologies. The MES of cerebral arteries were monitored by transcranial doppler (TCD), carotid atherosclerotic lesions were detected by color Doppler sonography and extracranial and intracranial magnetic resonance angiography were performed. Next, the severity of neurological deficits was evaluated using National Institutes of Health Stroke Scale (NIHSS) scores. Cases of stroke recurrence and post‑stroke mortality were recorded. A total of 135 patients were recruited, including 33 with CE, 49 with LA, 24 with SVD and 29 with stroke of other etiology. A significant difference in the incidence of MES was identified between the 4 subtypes (P=0.025). The occurrence of positive MES was found to markedly correlate with a history of coronary heart disease (P<0.001) and antithrombotic treatment (P=0.045) and increased levels low density lipoprotein (P=0.036). Compared with patients with negative MES, no significant changes in NIHSS scores were found in patients with positive MES on days 1 and 7 following admission. The incidence of recurrent stoke and post‑stroke mortality was elevated 3 months from the onset of CI. In conclusion, a significant difference in the occurrence of MES was identified between subtypes of patients with acute CI. The incidence of recurrent stroke and mortality was increased among patients with positive MES 3 months from onset.

View Figures

View References

1	Spencer MP, Thomas GI, Nicholls SC, et al: Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography. Stroke. 21:415–423. 1990. View Article : Google Scholar
2	No authors listed. Basic identification criteria of Doppler microembolic signals. Consensus Committee of the Ninth International Cerebral Hemodynamic Symposium. Stroke. 26:11231995. View Article : Google Scholar
3	Grosset DG, Georgiadis D, Kelman AW, et al: Detection of microemboli by transcranial Doppler ultrasound. Tex Heart Inst J. 23:289–292. 1996.PubMed/NCBI
4	Al-Mubarak N, Roubin GS, Vitek JJ, et al: Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation. 104:1999–2002. 2003. View Article : Google Scholar : PubMed/NCBI
5	Droste DW, Junker K, Hansberg T, et al: Circulating microemboli in 33 patients with intracranial arterial stenosis. Cerebrovasc Dis. 13:26–30. 2002. View Article : Google Scholar : PubMed/NCBI
6	Gao S, Wong KS, Hansberg T, et al: Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke. 35:2832–2836. 2004. View Article : Google Scholar : PubMed/NCBI
7	Sliwka U, Lingnau A, Stohlmann WD, et al: Prevalence and time course of microembolic signals in patients with acute stroke. A prospective study. Stroke. 28:358–363. 1997. View Article : Google Scholar : PubMed/NCBI
8	Wong KS, Gao S, Chan YL, et al: Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol. 52:74–81. 2002. View Article : Google Scholar
9	Kimura K, Minematsu K, Koga M, et al: Microembolic signals and diffusion-weighted MR imaging abnormalities in acute ischemic stroke. AJNR Am J Neuroradiol. 22:1037–1042. 2001.PubMed/NCBI
10	Nakajima M, Kimura K, Shimode A, et al: Microembolic signals within 24 hours of stroke onset and diffusion-weighted MRI abnormalities. Cerebrovasc Dis. 23:282–288. 2007. View Article : Google Scholar : PubMed/NCBI
11	Markus HS and MacKinnon A: Asymptomatic embolization detected by Doppler ultrasound predicts stroke risk in symptomatic carotid artery stenosis. Stroke. 36:971–975. 2005. View Article : Google Scholar
12	Iguchi Y, Kimura K, Kobayashi K, Yamashita S, Shibazaki K and Inoue T: Microembolic signals after 7 days but not within 24 hours of stroke onset should be predictor of stroke recurrence. J Neurol Sci. 263:54–58. 2007. View Article : Google Scholar : PubMed/NCBI
13	Valton L, Larrue V, le Traon AP, et al: Microembolic signals and risk of early recurrence in patients with stroke or transient ischemic attack. Stroke. 29:2125–2128. 1998. View Article : Google Scholar : PubMed/NCBI
14	DeGraba TJ, Hallenbeck JM, Pettigrew KD, et al: Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. Stroke. 30:1208–1212. 1999. View Article : Google Scholar : PubMed/NCBI
15	Hao WH, Leung KS, Wong, et al: The significance of microembolic signals and new cerebral infarcts on the progression of neurological deficit in acute stroke patients with large artery stenosis. Cerebrovasc Dis. 29:424–430. 2010. View Article : Google Scholar
16	Markus HS and Brown MM: Differentiation between different pathological cerebral embolic materials using transcranial Doppler in an in vitro model. Stroke. 24:1–5. 1993.
17	Junghans U and Siebler M: Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist. Circulation. 107:2717–2721. 2003. View Article : Google Scholar : PubMed/NCBI
18	Adams HP, Bendixen BH, Kappelle LJ, et al: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke. 24:35–41. 1993. View Article : Google Scholar : PubMed/NCBI
19	Goldstein LB, Jones MR, Matchar DB, et al: Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke. 32:1091–1098. 2001. View Article : Google Scholar
20	Nabavi DG, Arato S, Droste DW, et al: Microembolic load in asymptomatic patients with cardiac aneurysm, severe ventricular dysfunction and atrial fibrillation. Clinical and hemorheological correlates. Cerebrovasc Dis. 8:214–221. 1998. View Article : Google Scholar
21	Kumral E, Balkir K, Uzuner N, et al: Microembolic signal detection in patients with symptomatic and asymptomatic lone atrial fibrillation. Cerebrovasc Dis. 12:192–196. 2001. View Article : Google Scholar : PubMed/NCBI
22	Goertler M, Blaser T, Krueger S, et al: Cessation of embolic signals after antithrombotic prevention is related to reduced risk of recurrent arterioembolic transient ischaemic attack and stroke. J Neurol Neurosurg Psychiatry. 72:338–342. 2002. View Article : Google Scholar
23	Junghans U and Siebler M: Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist. Circulation. 107:2717–2721. 2003. View Article : Google Scholar : PubMed/NCBI
24	Delcker A, Schnell A and Wilhelm H: Microembolic signals and clinical outcome in patients with acute stroke - a prospective study. Eur Arch Psychiatry Clin Neurosci. 250:1–5. 2000. View Article : Google Scholar : PubMed/NCBI
25	Goertler M, Baeumer M, Kross R, et al: Rapid decline of cerebral microemboli of arterial origin after intravenous acetylsalicylic acid. Stroke. 30:66–69. 1999. View Article : Google Scholar : PubMed/NCBI
26	Lund C, Rygh J, Stensrød B, et al: Cerebral microembolus detection in an unselected acute ischemic stroke population. Cerebrovasc Dis. 10:403–408. 2000. View Article : Google Scholar : PubMed/NCBI
27	Abbott AL, Chambers BR, Stork JL, et al: Embolic signals and prediction of ipsilateral stroke or transient ischemic attack in asymptomatic carotid stenosis: a multicenter prospective cohort study. Stroke. 36:1128–1133. 2005. View Article : Google Scholar
28	Iosif C, Oppenheim C, Lamy C, et al: Bilateral hypoperfusion and normal diffusion MR images in a case of acute embolic stroke. Cerebrovasc Dis. 26:95–96. 2008. View Article : Google Scholar : PubMed/NCBI
29	Schlaug G, Benfield A, Baird AE, et al: The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology. 53:1528–1537. 1999. View Article : Google Scholar : PubMed/NCBI
30	Iguchi Y, Kimura K, Kobayashi K, et al: Microembolic signals at 48 hours after stroke onset contribute to new ischaemia within a week. J Neurol Neurosurg Psychiatry. 79:253–259. 2008. View Article : Google Scholar : PubMed/NCBI
31	Kang DW, Kwon SU, Yoo SH, et al: Early recurrent ischemic lesions on diffusion-weighted imaging in symptomatic intracranial atherosclerosis. Arch Neurol. 64:50–54. 2007. View Article : Google Scholar : PubMed/NCBI